Stemona alkaloids, featuring polycyclic structures and interesting bioactivities, constitute a distinct class from the Stemonaceae family. In this review, recent advances in the synthesis of these unique alkaloids are briefly discussed, highlighting the application of novel synthetic strategies to access the core structures, as well as creative solutions to the installation of multiple stereogenic centers. The literature reviewed in this article covers the publications from 2010 to November 2014, a period that witnessed the prosperity of the synthesis of Stemona alkaloids. Figure 1: The Stemona alkaloids covered in this review. Scheme 1: Hong's synthesis of (±)-stemoamide [8]. Scheme 2: Hong's synthesis of (-)-stemoamide [14].
Introduction
The earliest interest in natural products by humans originated from the needs for treating diseases through folk medicines. Applications of herbal extracts from the Stemonaceae family for the treatment of respiratory diseases and as anthelmintics in China and other eastern Asian countries have long been recorded [1] . The main components of these plants were identified as a class of architecturally complex and diverse alkaloids, namely the Stemona alkaloids. By the end of 2013, around 183 such alkaloids had been reported from species of three genera, Stemona, Croomia, and Stichoneuron [2] . Structurally, most of these polycyclic molecules share a characteristic pyrrolo [1,2-a] azepine core, or its variations, with one or two methyl--lactone substructures incorporated.
There were mainly two viewpoints for the classification of the Stemona alkaloids, according to their structural features [3] [4] [5] . Considering the increasing number of alkaloids isolated, as well as their biosynthetic correlations, the current criterion needs to be improved. Consequently, on the basis of the pioneering works of Pilli [3, 4] , Seger [6] , and Greger and Hofer [5, [7] [8] [9] , Wang and Chen recently proposed a classification of Stemona alkaloids built on the combination of biogenetic pathways and chemical features, leading to two classes (hemiterpenoid pyrrolidine-and monoterpenoid pyrrolidine-alkaloids) and fourteen types [2] .
The daunting molecular complexity and intriguing biological activities of Stemona alkaloids have stimulated significant interest from the synthetic community. Apart from the construction of their skeletons, the central challenge lies in the installation of multiple stereogenic centers. Only a limited number of targets were completely synthesized, compared with the efforts devoted and the natural compounds identified, some of which have been reviewed in the literature [3, 4, 10, 11] . Pilli and co-workers summarized the total syntheses reported during 1999 to 2009 [4] , as an update to their previous review [3] . In addition, Figueredo et al. comprehensively reviewed the synthetic approaches to Stemona alkaloids up to 2009, emphasizing strategies to access different structural moieties [10] . Recently, Zhang and co-workers contributed a systematic review on the progress toward the synthesis of stenine [11] .
The total synthesis of Stemona alkaloids has been actively pursued by chemists around the world over the past five years. As a complementary update to those earlier reports, we herein wish to highlight the most recent total/formal syntheses of these unique alkaloids from 2010 to November 2014, mainly focusing on the strategic solutions from different groups. The Stemona alkaloids referred in this review are grouped by the new classification proposal [2] , whose structures and revised numbering systems are listed as shown in Figure 1 .
Synthesis of hemiterpenoidpyrrolidine-class alkaloids

Stemoamide-type
To realize a general synthetic strategy towards stemoamide-type alkaloids, Hong and co-workers achieved an elegant synthesis of (±)-stemoamide (1) [12] employing a bioinspired iminium ion cyclization as the key step (Scheme 1). The vital hemiaminal intermediate 18 with a propargylsilane was prepared in four steps from the commercially available 15 and aldehyde 16. After extensive screening of different acids, FeCl 3 was found to be the optimal one for promoting the desired cyclization, leading to the pyrrolo[1,2-a]azepine framework 20 in a ratio of 3:1 (cis/trans). The diastereomeric mixture of 20 was directly subjected to the removal of the TBS group, followed by a ruthenium-catalyzed cyclocarbonylation [13] . Interestingly, trans-22 was obtained as the single product, whose structure was further confirmed by X-ray analysis. The crucial transformation could be explained by a plausible epimerization of the allenic alcohol in the catalytic cycle. Reduction of the double bond ultimately resulted in the accomplishment of the synthesis of (±)-stemoamide (1, 8 steps and 37% overall yield), in a concise manner. Notably, Hong's work represented the first and only example of the biomimetic synthesis of a Stemona alkaloid.
In the exploration of an enantioselective synthesis of (-)stemoamide [14] , Hong's group employed the asymmetric hydrogenation of alkynone 23 using Noyori's catalyst (24) , giving rise to the optically pure alcohol 25 (Scheme 2). Subsequent homologation of 25 provided 26, which could be further converted to the bicyclic 20a/b as a pair of an inseparable mixture (cis/trans 3:1), according to the similar sequence. To get rid of the undesired The development of a new methodology could always facilitate the synthesis of complex natural products. In this context, a concise formal synthesis of (±)-stemoamide was accomplished by Oltra et al. through a Ti-catalyzed synthesis of exocyclic allene [15] . As shown in Scheme 3, the known substituted succinimide 28 was converted to aldehyde 29 via three steps, which served as the precursor for the key cyclization. Under the optimized condition ([Cp 2 TiCl 2 ], Mn, TMSCl), the efficient generation of allenic alcohol 21 was realized. The synthesis of Hong's intermediate 21 represented a short entry to (±)-stemoamide, thus demonstrating the synthetic utility of the new method. Scheme 3: Formal synthesis of (±)-stemonamide [15] .
Qiu and co-workers recently reported a stereocontrolled synthesis of (±)-stemoamide, which relied on a reductive amination/ lactamization sequence to forge the crucial pyrrolo[1,2-a]azepine core (Scheme 4) [16] . Specifically, subjecting the known silyl enol ether 30 to a vinylogous Mukaiyama-Michael addition, followed by acetalization gave enoate 31. Acetal protection prevented the undesired Henry reaction between the corresponding aldehyde and methyl 4-nitrobutyrate 32, thus affording ketone 33 as the sole product after Michael addition and subsequent treatment with CuCN/Cs 2 CO 3 . The dicarbonyl intermediate, after acid hydrolysis, was converted to the natural product by reductive amination and simultaneous lactam formation. Scheme 4: Synthesis of (±)-stemonamide by Qiu and co-workers [16] .
The group of Wipf have contributed numerous successes in the realm of the total synthesis of Stemona alkaloids [17] [18] [19] [20] . In the period of this review, they carried out the synthesis of (-)sessilifoliamide C and (-)-9-epi-stemoamide (32, 8-epi-stemoamide in the original numbering system) [21] . As shown in Scheme 5, the pyrrolo[1,2-a]azepine nucleus was constructed via a ring-closing metathesis (RCM) with Grubbs' second generation catalyst, while the precursor 36 was formed by alkylation of pyrrolidinone 34 with iodide 35. After desilylation, the stage was set for the Eschenmoser-Claisen reaction under optimized microwave conditions, establishing the critical stereocenter efficiently for the -methyl-lactone motif in stemoamide. The resulting amide 40 was subjected to an iodolactonization, followed by reduction of the iodide and lactone -methylation. Thus, synthesis of the C9 epimer of stemoamide was achieved for the first time. By utilization of a similar strategy, Wipf et al. also finished the synthesis of (-)sessilifoliamide C, which will be discussed in the following section.
Umpolung chemistry was developed by Zheng and co-workers to realize the coupling of hemiaminals with activated alkenes, which was utilized as the key step in their synthesis of (±)-10,11-di-epistemoamide. (47, 9,10-di-epi-stemoamide in the original numbering system) [22] . The Mukaiyama-Michael reaction of 30 with acrolein, followed by BH 3 reduction of the resultant aldehyde provided 44 in 60% overall yield (Scheme 6). The key precursor 46 was then secured via condensation of alcohol 44 with succinimide and ensuing NaBH 4 reduction. Finally, the expected intramolecular radical coupling took place smoothly in the presence of 
Croomine-type
Sessilifoliamide J (2) represents the only example of a Stemona alkaloid with a unique indolizidine core, which was isolated in 2008 from S. sessilifolia [23] . Huang and co-workers reported in 2011 their first-generation of synthetic endeavors [24] , and established the absolute configuration of this target alkaloid (Scheme 7). Starting from the known glutarimide derivative 48, Grignard addition to the lactam followed by reduction of the resulting hemiaminal with Et 3 SiH, afforded the piperidinone 50 in 56% overall yield. The indolizidinone fragment was realized in another three steps, which was then treated with 2-methysilyloxy-furan (52) in the presence of TMSOTf. The vinylogous Mannich reaction took place smoothly to yield four diastereomers, in favor of the desired one, which by reduction and Bn deprotection, furnished alcohol 54. The remaining spiro lactone moiety was eventually installed through an oxidation/reductive coupling lactonization sequence, affording four isomers. The major isomer was identified as 9-episessilifoliamide J (56), while sessilifoliamide J (2) was obtained in only 4.2% yield over two steps.
Since the production of sessilifoliamide J was not efficient enough, Huang's group initiated an alternative approach [25] , which relied on a Corey lactonization to build the spiro lactone system [26] . As illustrated in Scheme 8, a modified approach of Hanessian was employed for the preparation of the indolizidinone skeleton 61 [27] . The synthesis took advantage of a vinylogous Mannich reaction between aminal 58 and (trimethylsiloxy)furan 59, followed by catalytic hydrogenation and treatment with NaOMe, leading to the bicyclic compound 61. Since a bis-lactonization strategy failed, the stepwise way was pursued to first install the spiro lactone. After 1096 Natural Product Communications Vol. 10 (6) 2015 Liu & Wang Scheme 5: Synthesis of (-)-9-epi-stemoamide by Wipf et al. [21] . \ Scheme 7: Synthesis of (-)-9-epi-sessilifoliamide J by Huang and co-workers [24] . extensive experimentation, the Ley oxidation/Corey lactonization procedure was demonstrated to be fit for producing the expected spiro -lactone, as a separable diastereomeric mixture (2:1) in favor of the desired one 63. With the ensuing diastereoselective methylation and desilylation secured, the stage was set for the establishment of the second lactone ring. The resulting aldehyde from Swern oxidation was directly subjected to an organozinc addition, giving rise to a pair of epimeric lactones 66a and 66b. The former could be converted to the natural (-)-sessilifoliamide J (2) after hydrogenation of the exocyclic double bond. Thus, the whole synthesis was accomplished in 14 steps and 6.7% overall yield from commercially available material.
Another synthesis of the croomine-type alkaloid was Figueredo's work on (-)-stemospironine (3) [28] , largely based on their previous efforts towards the proposed structure of stemonidine [29] . The key feature was the application of an intramolecular Horner-Wadsworth-Emmons (HWE) olefination to afford the requisite spiro--lactone (Scheme 9). As previously reported [29] , the core pyrrolo Very recently, Yang and co-workers described their total synthesis of racemic tuberostemospiroline (4) and stemona-lactam R (5) [30] . Essential for the success of their approach was the efficient generation of an oxaspirocycle from the 4-substituted-1-tosyl-1,2,3triazole intermediate. The chemistry of N-sulfonyl-1,2,3-triazoles has received much attention recently [31] , which was explored by the Yang group for the preparation of oxaspirocycles in this study. As shown in Scheme 10, the triazole 75 was treated with Rh 2 (Oct) 4 followed by addition of Grignard reagent 76 to provide the 2,2disubstituted tetrahydrofuran 77, through an -imino metal carbene intermediate. After allylation of 77 with allyl bromide, exposure of the resulting diene 78 to Hoveyda-Grubbs' catalyst gave the expected azepine 79 in excellent overall yield. The introduction of the lactone was then realized by way of RuCl 3 -catalyzed oxidation of tetrahydrofuran, while the 2-pyrrolidinone was formed through aminolysis of the corresponding ester. Finally, selective methylation of lactone using LiHMDS/MeI installed the crucial stereocenter at C12, resulting in the completion of the synthesis of (±)-tuberostemospiroline (4) . The conversion of tuberostemospiroline to a related alkaloid stemona-lactam R (5) was carried out via a three-step procedure, involving selenylation/oxidative elimination of the lactone, dihydroxylation of the resulting alkene, followed by reduction of the tertiary alcohol.
Synthesis of monoterpenoid pyrrolidine-class alkaloids
Protostemonine-type
The protostemonine-type alkaloids are relatively simple and may act as biogenetic precursors for other complex alkaloids of this class [2] . In this review period, Lindsley and co-workers disclosed the total synthesis of stemaphylline (6) and stemaphylline N-oxide (7) [32], according to their established methods to assemble the azabicyclic systems (Scheme 11) [33] .
By utilization of thiazolidine thione 81 as the starting point, the optically pure intermediate 82 was prepared over 13 steps, setting the stage for Grignard addition of 83 to the imine. The resulting chiral sulfinamide, after attachment of the unsaturated ester, was further transformed into pyrrolidine 88 through the sequence of deprotection and reductive amination, followed by allylation with bromide 87. As guided by the retrosynthetic analysis, the azepine and -methyl--lactone substructures were envisioned to be accessed through RCM of the corresponding tetraene. This idea proved to be feasible by treating 88 with CSA followed by Hoveyda-Grubbs II catalyst, finishing the skeleton of stemaphylline (6) . The anticipated natural product was obtained after reduction of two double bonds, which could be further converted to (-)stemaphylline N-oxide (7) in the presence of m-CPBA.
Stemonamine-type
Tu and co-workers investigated the synthesis of the stemonaminetype alkaloids closely, which resulted in the total synthesis of (±)stemonamine in 2008 based on a tandem semipinacol rearrangement-Schmidt reaction protocol [34] , as well as an alternative formal synthesis one year later [35] .
Following their improved route to (±)-stemonamine [35] , the Tu group finished the divergent synthesis of another three stemonamine-type alkaloids from a common intermediate [36, 37] . As depicted in Scheme 12, the synthesis commenced with the preparation of diketone 91, with a terminal alkyne attached, which served to incorporate the -methyl--lactone at a later stage. The pivotal Schmidt reaction proceeded smoothly using TiCl 4 to furnish azabicyclic 92 in a stereoselective manner. As previously recorded, an aldol condensation secured the cyclopentenone 93, setting the stage for the formation of the unsaturated spirolactone. Since the attempted Dieckmann condensation was unsuccessful, an alternative ketone-ester condensation approach was found as a perfect solution. The much anticipated tetracycle 95 was realized in 38% overall yield from carbonate 94, through condensation followed by lactam reduction. With the key intermediate 95 in hand, the final task involved installation of the remaining lactone at C4. Oxidative cleavage of the terminal alkene under K 2 OsO 4 -NaIO 4 conditions enabled the requisite aldehyde 96, which was further elaborated to the target (±)-maistemonine (8) employing Figueredo's protocol [21] . It should be noted that (±)-maistemonine was observed to exist as a mixture of 1:1 with (±)-isomaistemonine (9), by storing in CDCl 3 at room temperature, probably through a retro-Mannich/Mannich pathway [38] . The first synthesis of (±)isomaistemonine was thereby achieved, whose structure was verified by an X-ray analysis of the synthetic sample. Furthermore, (±)-stemonamide (10) was generated during cleavage of the terminal alkene under a forced condition, thus demonstrating a divergent synthesis of stemonamine-type alkaloids from the common intermediate 95. Scheme 11: Synthesis of (-)-stemaphylline and (-)-stemaphylline N-oxide by Lindsley et al. [32] .
Advances in the synthesis of Stemona alkaloids Natural Product Communications Vol. 10 (6) 2015 1099 Scheme 12: Total synthesis of (±)-maistemonine, (±)-isomaistemonine, and (±)-stemonamide by Tu et al. [36, 37] . Scheme 13: Tu's formal synthesis of (±)-stemonamine [40] . In the meantime, inspired by the work of Overman [39] , Tu et al. designed an intramolecular Prins-pinacol/Schmidt rearrangement cascade to efficiently build the tricyclic skeleton of (±)stemonamine (11) (Scheme 13) [40] . Specifically, the isomers 98a and 98b were obtained over five steps from the known ketone 97, which served as the important precursors for the key rearrangement. Both reactions of 98a and 98b were promoted by TiCl 4 , giving the desired fused system 99 in different ratios of epimers. The structure of 99 was further confirmed by X-ray crystallographic study after being converted to the ketone 100. A four-step procedure was then applied to introduce an alkene conjugated to the ketone and a methyl group at the -position from 100. Relying on the previously reported method, the synthesis of the known intermediate 101 constituted a new formal synthesis of (±)-stemonamine.
Recently, the group of Rhee reported another efficient access to the key intermediate 100 employed in Tu's synthesis. The pivotal feature involved a one-pot gold(I)-mediated domino cyclization and SnCl 4 -catalyzed Schmidt rearrangement [41] . As illustrated in Scheme 14, the enyne 103 was prepared in 5 steps from ketone 102, which was subjected to the optimized condition, leading to tricyclic framework 104 with 84% yield. Moreover, oxidative cleavage of the exocyclic double bond in 104 delivered the known ketone 100, thus accomplishing the formal synthesis of (±)-stemonamine.
Stemofoline-type
The cage-like stemofoline-type alkaloids, which were considered to be the most complex members of the family, have been persistently pursued in the community. Despite the efforts, only two racemic syntheses were documented by Kende [42] and Overman [43] , respectively, until Martin and co-workers accomplished an enantioselective formal synthesis in 2012 [44, 45] . In this context, starting from enantiomerically pure 2-deoxy-D-ribose (105), the crucial diazo intermediate 106 was produced via a sequence of transformations over 12 steps (Scheme 15). In the presence of Rh 2 (OAc) 4 and pivotal TFA·Et 3 N, an impressive one-pot multiplestep cascade reaction took place to afford the advanced tricycle 109 with remarkable efficiency. The transformation was believed to proceed through the S-shaped ylide 107 and ensuing intramolecular 1,3-dipolar cycloaddition, consequently giving the tricyclic core as a single isomer. Having 109 secured, subsequent functional group manipulations led to the formation of ketone 110. -Alkylation of the latter, followed by base-mediated epimerization, and further treatment with TFA, forged the hemiacetal 111 in 50% overall yield. According to Overman's total synthesis of didehydrostemofoline (12a) and isodidehydrostemofoline (12b) [43] , preparation of the optically pure intermediate 111 completed the enantioselective formal synthesis of both alkaloids.
Stichoneurine-type
Having demonstrated that the [3, 3] -sigmatropic rearrangement was feasible for the installation of the C10 stereocenter in the synthesis of (-)-9-epi-stemoamide, Wipf and co-workers explored the synthesis of (-)-sessilifoliamide C (13) relying on the same principle [21] . As illustrated in Scheme 16, a butyric acid was attached to the previously prepared intermediate 38, which after optimization, was subjected to Ireland-Claisen rearrangement of the TIPS-silyl ketene acetal, providing the silyl ester 113 as a diastereomeric mixture (6:1). Further elaboration to the aldehyde 115 was realized in five steps, and the undesired minor isomers were successfully removed by chromatography. Treatment of the aldehyde with vinyl magnesium bromide, followed by in situ acylation with 116, led to the formation of the diastereomeric diene 117 in a ratio of 2:1. Ultimately, synthesis of the target (-)sessilifoliamide C was achieved for the first time, as the major isomer from the closing RCM.
Stenine-type
During the period of this review, the total synthesis of stenine (14) , the representative member of the stenine-type alkaloids [46] , continued to receive much attention. By utilization of an enantioselective double Michael addition, Zhang's group accomplished an expedient synthesis of (-)-stenine [47] , while Fujioka reported another synthesis of the target employing their established chiral auxiliary [48] .
Zhang's synthesis of stenine began with the rapid preparation of building blocks 118 and 119 from commercially available materials, in four and two steps, respectively (Scheme 17). After extensive investigations, the critical double Michael addition was realized in one-pot utilizing Evans catalyst 120 [49] , with subsequent treatment with KOH/SiO 2 under ultrasound, leading to the key intermediate 121. Notably, four continuous stereogenic centers around the cyclohexanone ring were secured with remarkable efficiency in Advances in the synthesis of Stemona alkaloids Natural Product Communications Vol. 10 (6) 2015 1101 one-pot. Subsequent intramolecular aminocyclization and amidation constructed the tricyclic core 122 from the preinstalled functional groups. Assembly of the remaining -lactone called for an acetate chain at C14, which was attached through a decarboxylation / alkylation sequence. With the keto ester 123 in hand, reduction of the adjacent ketone enabled the formation of the required lactone 124 in 51% yield, after recrystallization. Ultimately, conversion of the intermediate 124 to (-)-stenine was carried out via a selective lactone -methylation, with ensuing amide reduction. The strategy developed by Zhang and co-workers finished the synthesis of (-)stenine concisely in 14 steps from commercially available materials, which as well represented the first catalytic, enantioselective version for the accomplishment of the target molecule.
In the same year, Fujioka et al. described their synthesis of (-)stenine [48] , which relied on the pivotal precursor 125 from an intramolecular haloetherification chemistry (Scheme 18) [50] . In this context, the chiral intermediate 125 was transformed into 126 by sequential -allylation and conjugate addition. Further functional group manipulations of the latter including the incorporation of a nitrogen atom delivered compound 127. After removal of the PMB group, the stage was set for the Mitsunobu reaction, generating the bicyclic system in moderate yield (55%). Furthermore, elaboration of the terminal diene 128 to diester 129, followed by lactam formation, proceeded smoothly to arrive at the tricyclic framework 130. An analogous method was employed for the formation of the -lactone, thereby concluding the final transformation into stenine. It is noteworthy that the key intermediate 125 was also applied to the synthesis of 1-epi-stenine (9-epi-stenine in the original numbering system), which demonstrated the versatility of this chiral auxiliary based strategy.
Conclusions
As summarized in this review, the total synthesis of Stemona alkaloids continued to spark the interest of organic synthetic laboratories, which could be reflected by the uninterrupted achievements in the recent five years. Seven different types of alkaloids in total were explored and accomplished, including not only the molecules that were synthesized for the first time to unambiguously confirm the structures and stereochemistry, but also those old targets accessed with improved conciseness and efficiency by novel strategic designs. It is therefore anticipated that the synthesis of Stemona alkaloids and analogues will keep increasing, in view of the evolution of their biogenetic relationships, structural diversity, and biological potential.
